• Alda 1 (SKU B5508): Optimizing ALDH2 Activation in Cardiac M

  2026-05-24

  This article guides biomedical researchers through scenario-driven challenges in ALDH2 activation assays, highlighting Alda 1 (SKU B5508) for its reproducible enzymatic enhancement in both wild-type and variant ALDH2. Practical Q&A illustrates reliable protocol design, data interpretation, and vendor comparison, supporting robust research in cardiac ischemia and aldehyde detoxification.

• SIRT4 Regulation of Glutamine Metabolism Mitigates Liver Fib

  2026-05-23

  The reference study elucidates how targeting glutamine metabolism in hepatic stellate cells (HSCs), particularly through SIRT4-mediated regulation of glutamate dehydrogenase (GDH), attenuates liver fibrosis. These findings provide mechanistic insights and highlight new molecular targets for antifibrotic therapies.

• (Z)-4-Hydroxytamoxifen: Precision Estrogen Receptor Modulato

  2026-05-22

  (Z)-4-Hydroxytamoxifen enables high-fidelity estrogen receptor (ER) modulation for dissecting breast cancer signaling and resistance mechanisms. This guide delivers actionable workflows, troubleshooting strategies, and protocol optimizations that leverage its superior receptor affinity and antiestrogenic profile.

• Berberine, SIRT6-AMPK, and NLRP3 Inflammasome in Atrial Fibr

  2026-05-22

  This study reveals that berberine prevents angiotensin II-induced atrial fibrosis and the development of atrial fibrillation by upregulating the SIRT6-AMPK pathway and inhibiting NLRP3 inflammasome activation. These findings clarify key molecular mechanisms underlying atrial remodeling and position SIRT6-AMPK as a promising target for therapeutic intervention.

• Cefoperazone Sodium Salt: Applied Workflows in Antibacterial

  2026-05-21

  Cefoperazone (sodium salt) stands out for its β-lactamase stability and robust activity against both gram-positive and gram-negative bacilli, making it a gold standard for in vitro antimicrobial assays and resistance studies. This guide delivers actionable protocols, troubleshooting strategies, and practical insights that empower researchers to achieve reproducible, high-sensitivity results in challenging bacterial infection models.

• Ruxolitinib Phosphate (INCB018424): Applied JAK/STAT Modulat

  2026-05-21

  Ruxolitinib phosphate (INCB018424) unlocks precision control of the JAK/STAT pathway for translational autoimmune and oncology models. Here, we dissect workflow refinements, pivotal mechanistic findings, and troubleshooting strategies that amplify its experimental value and reproducibility.

• c-Myc tag Peptide: Precision Displacement and Workflow Maste

  2026-05-20

  The c-Myc tag Peptide unlocks unmatched specificity for displacing c-Myc-tagged fusion proteins in immunoassays, enabling high-fidelity studies of transcription factor regulation and cancer biology. This guide details experimental workflows, troubleshooting strategies, and new insights derived from the latest research, maximizing the peptide’s value in cutting-edge bench applications.

• Cisplatin and Ferroptosis: Next-Gen Strategies for Overcomin

  2026-05-20

  Explore how Cisplatin (CDDP) not only induces apoptosis but also interacts with ferroptosis pathways to overcome chemotherapy resistance in cancer research. This article uniquely analyzes recent mechanistic breakthroughs, providing researchers with advanced insights for assay design.

• GPNMB-Based Model Predicts Immunotherapy Response in ESCC

  2026-05-19

  This study introduces a clinically validated, multimodal model integrating circulating GPNMB and CAF-Epi niche features to predict immunotherapy response in esophageal squamous cell carcinoma (ESCC). The findings advance precision oncology by elucidating tumor–immune crosstalk mechanisms and providing robust, scalable biomarkers for patient stratification.

• Remdesivir (GS-5734): Advanced Workflows for Antiviral Resea

  2026-05-19

  Remdesivir (GS-5734) drives robust, reproducible inhibition of RNA viruses in both cell-based and in vivo models, empowering research on coronaviruses, Ebola, and emerging threats. This guide details cutting-edge experimental setups, protocol refinements, and troubleshooting strategies to maximize Remdesivir’s impact in translational virology.

• Imipramine in Autophagy and Apoptosis Research Workflows

  2026-05-18

  Imipramine, a classic tricyclic antidepressant, is redefining research in oncology and neuroscience by enabling reproducible autophagy and apoptosis assays. This article details protocol enhancements, lipidomics-driven insights, and troubleshooting strategies to maximize experimental clarity and efficiency with Imipramine from APExBIO.

• SM-102 in mRNA Delivery: Optimized Protocols and Use-Cases

  2026-05-18

  SM-102 enables high-efficiency mRNA delivery via lipid nanoparticles, streamlining vaccine and therapeutic development workflows. This guide translates cutting-edge evidence and machine learning insights into actionable protocols, troubleshooting, and comparative advantages for translational research.

• Prochlorperazine for Acute Mountain Sickness: Study Protocol

  2026-05-17

  Small et al. present a randomized, double-blind clinical trial protocol evaluating prochlorperazine maleate versus placebo for the prevention of acute mountain sickness (AMS) during rapid ascent. This work introduces a mechanistically rational, alternative approach to AMS prophylaxis based on the drug’s established antiemetic and migraine-relief properties, with potential implications for clinical and translational research.

• Anlotinib Hydrochloride: Multi-Target TKI for Angiogenesis A

  2026-05-16

  Anlotinib hydrochloride stands out as a potent multi-target tyrosine kinase inhibitor, delivering reproducible anti-angiogenic outcomes in advanced cancer research. This guide details optimized protocols, troubleshooting insights, and data-driven advantages that set APExBIO’s Anlotinib hydrochloride apart for endothelial cell migration and pathway inhibition workflows.

• Cy5 NHS ester(Et): Technical Guidance for Fluorescent Labeli

  2026-05-15

  Cy5 NHS ester(Et) enables water-soluble, high-purity fluorescent labeling of proteins and other biomolecules by targeting primary amines. It is best suited for workflows such as immunofluorescence staining, flow cytometry, and fluorescence microscopy, but should not be used in ethanol-based protocols or for long-term storage of labeling solutions.

413 records 8/28 page Previous Next First page 上5页 678910 下5页 Last page